Health Dictionary
Reliable, easy-to-read patient information on common medical conditions — written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
R-CHMP regimen
Introduction
Synonyms and keywords: Rituximab-Cyclophosphamide-Hydroxydaunorubicin-Marqibo-Prednisone regimen
Overview
Overview
R-CHMP regimen refers to a regimen consisting of rituximab, cyclophosphamide , doxorubicin (hydroxydaunorubicin), vincristine (Marqibo), and prednisone used to treat aggressive non-Hodgkin’s lymphoma.[1]
Regimen
Regimen
RRituximab (Rituxan)
CCyclophosphamide (Cytoxan)
HDoxorubicin (Hydroxydaunorubicin)
MVincristine liposomal (Marqibo)
PPrednisone
References
References
- ↑ 1.0 1.1 Hagemeister F, Rodriguez MA, Deitcher SR, Younes A, Fayad L, Goy A; et al. (2013). “Long term results of a phase 2 study of vincristine sulfate liposome injection (Marqibo(®) ) substituted for non-liposomal vincristine in cyclophosphamide, doxorubicin, vincristine, prednisone with or without rituximab for patients with untreated aggressive non-Hodgkin lymphomas”. Br J Haematol. 162 (5): 631–8. doi:10.1111/bjh.12446. PMID 23802738.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aparna Vuppala, M.B.B.S. [2]